Senior Director, Oncology Health Economics and Real-Word Evidence

Corcept Therapeutics

  • Full Time

Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

The Sr. Director, Oncology Health Economic and Real-World Evidence will report to the VP, Market Access, Oncology, and will play a key role in supporting HCP adoption and patient access by leading the team responsible for collaborating to develop the value strategy and platform for relacorilant in oncology. This role will collaborate with developing evidence generation and publication plans to support the value of relacorilant in oncology indications and will coordinate strategy with the medical and development teams. The team will also support the account teams in educating payers and formulary decision makers on clinical, HEOR, and RWE to support adoption and patient access to relacorilant.

Responsibilities:

  • Brand Value Strategy and Platform – Collaborate with Access Marketing to formulate the brand value strategy and platform to support payer coverage and account adoption of relacorilant
  • Collaborate with Access marketing to Develop Value Resources – Collaborate to develop payer and formulary decision-maker resources leveraging the value platform and messaging to support access and adoption of relacorilant
  • Evidence Generation and Publication Plan – Develop Health Economic and RWE evidence generation plan and publication plan aligned with brand strategy
  • Collaboration with Medical and Development Organizations – Collaborate with and support Medical and Development organizations to provide HEOR/RWE input to strategic planning and medical and development strategy
  • Customer Engagement and Account Team Support – Coordinate customer engagements with payer and account teams to present clinical and value evidence to payers and formulary decision makers to support patient access to relacorilant

Preferred Skills, Qualifications and Technical Proficiencies:

  • Experience leading Oncology HEOR and RWE teams
  • Experience with oral oncology therapies and community oncology practices with dispensing capabilities
  • Experience launching oral oncology therapies in the community oncology setting
  • Demonstrated ability to manage, lead, and coach teams to meet objectives and drive results within agreed-upon timelines
  • Effective oral and written communication skills and ability to engage all levels of the organization including the C-Suite level
  • Excellent negotiation skills with a focus on finding solutions to meet organizational goals
  • Collaborative style fostering cross-functional collaboration and partnership to meet organizational goals
  • Working knowledge of US healthcare policies and relevant legal, compliance, regulatory, and reporting requirements

Preferred Education and Experience:

  • PharmD, Advanced degree in Health Economics, PhD preferred
  • 15 years of pharmaceutical experience, oncology experience preferred, with a focus on HEOR and RWE

 #LI-Remote

The pay range that the Company reasonably expects to pay for this position is $252,000 – $300,000; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

 Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

 Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview.  Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.

 

Receive job alerts twice per week:

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Choose one or more global alerts or browse to the USA and UK alert pages:



USA Specific Job Alerts
UK Specific Job Alerts

Our marketing platform's terms of use